Journal
/
/
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
JoVE Journal
Immunology and Infection
This content is Free Access.
JoVE Journal Immunology and Infection
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
DOI:

08:46 min

November 12, 2019

, , , , , , , , , , , , ,

Chapters

  • 00:04Title
  • 00:30Chimeric Antigen Receptor (CAR)-Encoding Lentivirus Generation
  • 02:29CAR T Cell Generation and Expansion
  • 03:16CAR Expression Detection
  • 04:55Real-Time Cytolysis Potency Assay
  • 06:48Results: Representative CAR T Cell Target Cell Killing Efficacy as Assessed by RTCA
  • 08:05Conclusion

Summary

Automatic Translation

We describe a quantitative real-time in vitro cytolysis assay system to evaluate the potency of chimeric antigen receptor T cells targeting liquid and solid tumor cells. This protocol can be extended to assess other immune effector cells, as well as combination treatments.

Related Videos

Read Article